Figure 1
From: Deregulation of the miR-16-KRAS axis promotes colorectal cancer

The expression of KRAS in human CRC tissues.
(A and B) Western blot analysis of the KRAS protein levels in 16 pairs of CRC and NAT samples. GAPDH was used as a loading control. A: representative image; B: Quantitative analysis (KRAS protein vs. GAPDH protein). (C) Quantitative RT-PCR analysis of the KRAS mRNA levels (KRAS mRNA vs. GAPDH mRNA) in the same 16 pairs of CRC and NAT samples. (mean ± S.D; ***p < 0.001).